Intravitreal sirolimus for persistent, exudative age-related macular degeneration: a Pilot Study

BACKGROUND AND OBJECTIVE: To evaluate the safety and efficacy of intravitreal sirolimus for persistent, exudative age-related macular degeneration (AMD). METHODS: This institutional review board approved, registered (NCT02357342), prospective, subject-masked, single center, randomized controlled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Minturn, Robert J., Bracha, Peter, Klein, Margaret J., Chhablani, Jay, Harless, Ashley M., Maturi, Raj K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885608/
https://www.ncbi.nlm.nih.gov/pubmed/33593448
http://dx.doi.org/10.1186/s40942-021-00281-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885608/
https://www.ncbi.nlm.nih.gov/pubmed/33593448
http://dx.doi.org/10.1186/s40942-021-00281-0

Ejemplares similares